Vortioxetine Improved Depressive State In Parkinson's Disease

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder often accompanied by depression.
• Managing depression in PD patients presents challenges due to potential drug interactions and symptom overlap.

Observation:

• A 67-year-old Japanese female with Parkinson's disease (PD) experienced worsening depression despite treatment with levodopa.
• The patient had previously shown no improvement with paroxetine and escitalopram for her depressive symptoms.

Findings:

• Vortioxetine was administered to the patient, leading to a significant improvement in her depression.
• The treatment with vortioxetine did not exacerbate the patient's existing Parkinson's disease symptoms.

Implications:

• Vortioxetine may be a viable therapeutic option for depression in Parkinson's disease patients.
• This case highlights the potential for vortioxetine to manage comorbid depression in neurodegenerative conditions without worsening motor symptoms.